Filing summary: LaserLock Technologies, Inc. FY2014 Form 10-K
Identity and period: The provided filing is for LaserLock Technologies, Inc. (OTC: LLTI), not Openworld, Inc. It is an annual report for the year ended December 31, 2014, not a standalone Q4 filing. The company develops physical anti-counterfeiting inks and digital identity/authentication technology.
Financial results and position
| Metric | FY2014 / Dec. 31, 2014 | FY2013 / Dec. 31, 2013 |
|---|---|---|
| Revenue | $124,598 | $3,140 |
| Gross profit | $11,574; approximately 9.3% gross margin | $430; approximately 13.7% gross margin |
| Operating expenses | $13,576,909 | $11,641,599 |
| Net loss | $7,918,495 | $16,390,869; $17,390,869 applicable to common stockholders after a deemed dividend |
| Net cash used in operations | $2,020,017 | $2,788,769 |
| Cash | $63,956 | $1,285,973 |
| Current assets / current liabilities | $342,402 / $6,204,205 | $1,513,291 / $1,183,452 |
| Total liabilities | $12,712,799 | $7,814,378 |
| Stockholders’ deficit | $12,125,793 | $5,999,121 |
- Revenue rose, but remained very small relative to operating costs. The reported loss narrowed largely because of a $5.13 million gain from changes in warrant fair value and lower stock-option compensation than in 2013—not because the business reached meaningful scale.
- R&D expense was $10.59 million in the audited statements, including substantial stock and warrant consideration for technology. The filing reports $5.74 million of stock and warrants issued for technology in the cash-flow reconciliation.
- Financing provided $798,000 of cash in 2014, all from debt issuance. The company had no commercial bank credit facility. Cash was approximately $5,000 as of April 13, 2015, according to management.
- Warrant liabilities were $6.37 million at year-end. The balance sheet also reports $812,553 of notes payable and $114,000 of current senior convertible notes, as well as related-party accrued interest.
Changes, outlook and material risks
- Management’s stated 12–24 month priority was to market the products and generate enough revenue to cover operating expenses. It said additional financing would be needed and warned that dilution, inability to raise funds, weak sales, competition, and limited resources could prevent execution of its plans.
- The independent auditor identified substantial doubt about the company’s ability to continue as a going concern. Management likewise said existing cash was insufficient to sustain operations and that continued operations depended on financing, expense reductions, or revenue growth.
- Multiple notes were in default at December 31, 2014, including $650,000 of 8% notes issued in 2014, a $50,000 overdue Series A note, and other notes described as past due. The filing’s debt schedule and balance-sheet classifications should be reviewed carefully.
- A $4.5 million payment under the VerifyMe patent and technology license arrangement was accrued, with settlement contemplated through shares and warrants. The obligation was described as contingent on technology being patentable and licensable; the company said it had not reached that conclusion and offered no assurance the technology would qualify. At the reported share price, the filing estimated substantial potential share and warrant issuance.
- The company disclosed that certain 2014 financing transactions may have violated VerifyMe agreement terms, potentially triggering consent, put, anti-dilution, or preemptive rights. It was negotiating for consent and waivers.
- Management concluded disclosure controls were effective, but internal control over financial reporting was not effective at year-end, citing staffing changes near the filing date. The auditor did not attest to internal controls.
- The company reported seven U.S. patents and pending U.S. and foreign applications. Management cited an independent valuation of pigment patents at approximately $9.5 million; the balance sheet carried patents and trademark at $107,586 net.
Important facts for investors to verify
- Confirm the issuer and reporting period: this text is LaserLock’s FY2014 Form 10-K, not an Openworld filing or a Q4-only report.
- Reconcile the audited statements with narrative figures: the filing’s MD&A gives different amounts for certain expenses, and the business section states 2014 R&D costs of $5,698,182 versus $10,590,271 in the audited statements.
- Verify the status, amounts, maturity dates, defaults, and any subsequent repayment or restructuring of notes, including the related-party debt and accrued interest.
- Determine whether the $4.5 million VerifyMe obligation is enforceable, whether its contingencies were satisfied, and the likely share and warrant dilution; also confirm the status of the alleged agreement violations and any related rights.
- Assess near-term liquidity and financing needs, including subsequent borrowing, unpaid liabilities, and whether the company can continue as a going concern.
- Review fully diluted capitalization and potential dilution from outstanding options, warrants, preferred stock, and the contemplated technology-payment securities; the filing reports 307,578,149 common shares outstanding on April 15, 2015.